1. Home
  2. PRTA vs ODC Comparison

PRTA vs ODC Comparison

Compare PRTA & ODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • ODC
  • Stock Information
  • Founded
  • PRTA 2012
  • ODC 1941
  • Country
  • PRTA Ireland
  • ODC United States
  • Employees
  • PRTA N/A
  • ODC N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • ODC Miscellaneous manufacturing industries
  • Sector
  • PRTA Health Care
  • ODC Consumer Discretionary
  • Exchange
  • PRTA Nasdaq
  • ODC Nasdaq
  • Market Cap
  • PRTA 809.8M
  • ODC 853.6M
  • IPO Year
  • PRTA N/A
  • ODC N/A
  • Fundamental
  • Price
  • PRTA $5.80
  • ODC $56.15
  • Analyst Decision
  • PRTA Buy
  • ODC
  • Analyst Count
  • PRTA 9
  • ODC 0
  • Target Price
  • PRTA $27.67
  • ODC N/A
  • AVG Volume (30 Days)
  • PRTA 2.2M
  • ODC 46.7K
  • Earning Date
  • PRTA 08-07-2025
  • ODC 06-05-2025
  • Dividend Yield
  • PRTA N/A
  • ODC 1.28%
  • EPS Growth
  • PRTA N/A
  • ODC 17.38
  • EPS
  • PRTA N/A
  • ODC 3.40
  • Revenue
  • PRTA $137,935,000.00
  • ODC $474,062,000.00
  • Revenue This Year
  • PRTA N/A
  • ODC N/A
  • Revenue Next Year
  • PRTA $30.93
  • ODC N/A
  • P/E Ratio
  • PRTA N/A
  • ODC $17.04
  • Revenue Growth
  • PRTA 54.55
  • ODC 9.92
  • 52 Week Low
  • PRTA $4.32
  • ODC $29.47
  • 52 Week High
  • PRTA $25.42
  • ODC $60.32
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 46.16
  • ODC 70.66
  • Support Level
  • PRTA $4.95
  • ODC $56.21
  • Resistance Level
  • PRTA $6.00
  • ODC $57.93
  • Average True Range (ATR)
  • PRTA 0.32
  • ODC 1.76
  • MACD
  • PRTA 0.25
  • ODC 0.29
  • Stochastic Oscillator
  • PRTA 88.59
  • ODC 75.88

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

About ODC Oil-Dri Corporation Of America

Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups namely Retail and Wholesale Products Group and Business to Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.

Share on Social Networks: